Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
25 sep 2008 - 07:17
Statutaire naam
Crucell N.V.
Titel
Lonza and Crucell enter into long term agreement
Bericht
Basel, Switzerland / Leiden, The Netherlands (September 25, 2008) – Lonza (Swiss Exchange: LONN) and Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) entered into a co-exclusive manufacturing, sales and distribution agreement related to the PERMEXCIS™ cell culture medium developed by Crucell for PER.C6® cells. Under this agreement, Lonza will manufacture the medium, and in addition will market and sell it on a global basis. Financial details of the agreement were not disclosed.
Datum laatste update: 09 januari 2026